Drug Formulation with Cyclodextrins

Velesco is a niche contract research organization (CRO) specializing in early phase drug development.  One of our core competencies is formulation of compounds for early toxicology studies.  We take a targeted, scientific approach to pharmaceutical formulation.

 

One of our tools for formulation of poorly soluble early stage compounds is the family of cyclodextrins.

 

To learn more about how Velesco is utilizing cyclodextrins in early phase drug development, download our free whitepaper describing cyclodextrins and how they can be used as early stage solubilizers.

News and Events

 

Lisa Crandall, MS, and Peter Angus, PhD, spoke with Pharmaceutical Technology about the best practices in stability testing.  Read the interview here.

 

                                                                              Velesco has expanded our analytical facilities in a new Wixom, Michigan location with the help of the Bank of Ann Arbor Technology Industry Group.                          Read the press release here.

  

CEO Dave Barnes has been published in a new Pharmoutsourcing article on Clinical Trial Materials and Manufacturing

  

2 new job postings! Careers 

  

Velesco's work published 

  Formulation Development & Manufacturing:

Using a Single Provider Reduces Costs & Risk

Read it here.

  

Follow Velesco: 

 LinkedIn IN Icon 25px Google+ Follow VelescoPharma on Twitter  FB FindUsOnFacebook 100

 

734-274-9877